News

Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up ...
Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic ...